Uscom Ltd (UCM) - Total Liabilities

Latest as of June 2025: AU$3.29 Million AUD ≈ $2.33 Million USD

Based on the latest financial reports, Uscom Ltd (UCM) has total liabilities worth AU$3.29 Million AUD (≈ $2.33 Million USD) as of June 2025. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Explore UCM cash flow conversion to assess how effectively this company generates cash.

Uscom Ltd - Total Liabilities Trend (2003–2025)

This chart illustrates how Uscom Ltd's total liabilities have evolved over time, based on quarterly financial data. Check Uscom Ltd liquid asset ratio to evaluate the company's liquid asset resilience ratio.

Uscom Ltd Competitors by Total Liabilities

The table below lists competitors of Uscom Ltd ranked by their total liabilities.

Company Country Total Liabilities
Cyanotech Corporation
NASDAQ:CYAN
USA $15.20 Million
Playfair Mining Ltd.
V:PLY
Canada CA$83.06K
Baronsmead Second Venture Trust Plc
LSE:BMD
UK GBX1.47 Million
Bounty Oil & Gas NL
AU:BUY
Australia AU$4.08 Million
Mantex AB
ST:MANTEX
Sweden Skr12.63 Million
QVC Group Inc
NASDAQ:QVCGA
USA $10.54 Billion
TELES Informationstechnologien AG
XETRA:TLIK
Germany €4.29 Million
Celtic PLC
LSE:CCP
UK GBX89.90 Million

Liability Composition Analysis (2003–2025)

This chart breaks down Uscom Ltd's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the full company profile including market capitalisation, see market cap of Uscom Ltd.

Liquidity & Leverage Metrics

Key Metrics Explained

Metric Value Description
Current Ratio 0.95 Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities)
Quick Ratio N/A More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities)
Cash Ratio 0.35 Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities)
Debt to Equity -85.97 Measures financial leverage (Total Liabilities ÷ Shareholder Equity)
Debt to Assets 1.01 Portion of assets financed with debt (Total Liabilities ÷ Total Assets)

Liability Trends Comparison

This chart compares key liability metrics across different time periods, showing how Uscom Ltd's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.

Annual Total Liabilities for Uscom Ltd (2003–2025)

The table below shows the annual total liabilities of Uscom Ltd from 2003 to 2025.

Year Total Liabilities Change
2025-06-30 AU$3.29 Million
≈ $2.33 Million
+58.48%
2024-06-30 AU$2.07 Million
≈ $1.47 Million
-2.93%
2023-06-30 AU$2.14 Million
≈ $1.51 Million
+3.81%
2022-06-30 AU$2.06 Million
≈ $1.46 Million
-8.85%
2021-06-30 AU$2.26 Million
≈ $1.60 Million
-9.53%
2020-06-30 AU$2.50 Million
≈ $1.77 Million
+283.27%
2019-06-30 AU$650.99K
≈ $460.62K
+22.65%
2018-06-30 AU$530.76K
≈ $375.55K
-25.06%
2017-06-30 AU$708.23K
≈ $501.12K
-8.47%
2016-06-30 AU$773.75K
≈ $547.48K
+19.46%
2015-06-30 AU$647.69K
≈ $458.28K
+43.99%
2014-06-30 AU$449.82K
≈ $318.27K
-2.32%
2013-06-30 AU$460.52K
≈ $325.85K
+28.53%
2012-06-30 AU$358.29K
≈ $253.51K
-7.82%
2011-06-30 AU$388.69K
≈ $275.02K
+1.91%
2010-06-30 AU$381.38K
≈ $269.85K
-18.73%
2009-06-30 AU$469.31K
≈ $332.06K
+32.46%
2008-06-30 AU$354.31K
≈ $250.70K
-19.18%
2007-06-30 AU$438.38K
≈ $310.18K
-31.64%
2006-06-30 AU$641.30K
≈ $453.76K
+72.18%
2005-06-30 AU$372.46K
≈ $263.54K
+19.50%
2004-06-30 AU$311.69K
≈ $220.54K
+315.28%
2003-06-30 AU$75.06K
≈ $53.11K
--

About Uscom Ltd

AU:UCM Australia Medical Devices
Market Cap
$2.21 Million
AU$3.12 Million AUD
Market Cap Rank
#29592 Global
#1753 in Australia
Share Price
AU$0.01
Change (1 day)
+0.00%
52-Week Range
AU$0.01 - AU$0.02
All Time High
AU$0.48
About

Uscom Limited designs, develops, manufactures, and markets non-invasive cardiovascular and pulmonary medical devices in Australia, Asia, the Americas, and Europe. It offers USCOM 1A, a non-invasive hemodynamic monitor that measures blood flow, stroke volume, and cardiac output; and BP+, a supra-systolic oscillometric central blood pressure monitor that measures blood pressure and blood pressure w… Read more